IB Acquisition Corp.

IBACR ·Healthcare, Diagnostics & Research, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023
Operating Activities
Net Income $3.4M $1.9M $-6.8K
Depreciation & Amortization — — —
Depreciation — — —
Amortization — — —
Stock-Based Compensation — — —
Net Cash from Operating Activities $-1.3M $-821.0K $-207
Investing Activities
Capital Expenditures — — —
Business Acquisitions — — —
Net Cash from Investing Activities $107.8M $-115.6M —
Financing Activities
Dividends Paid — — —
Stock Repurchases $106.1M — —
Net Cash from Financing Activities $-106.1M $117.2M $50.0K
Net Change in Cash — — —
Free Cash Flow — — —